Research programme: beta-amyloid vaccine - MerckAlternative Names: Anti-Aβ vaccine - Merck
Latest Information Update: 26 Aug 2011
At a glance
- Originator Merck & Co
- Class Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 26 Aug 2011 No development reported - Preclinical for Alzheimer's disease in USA (Injection)
- 02 Nov 2006 Preclinical trials in Alzheimer's disease in USA (Injection)